Craft

Invitae

Revenue

$516.3 M

FY, 2022

Invitae Summary

Company Summary

Overview
Invitae is a company engaged in medical genetic testing. It specializes in genetic diagnostics for hereditary disorders. The company offers genetic tests in various clinical areas including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions, and rare diseases, as well as prenatal and perinatal genetic tests.
Type
Subsidiary
Status
Active
Founded
2010
HQ
San Francisco, CA, US | view all locations
Website
https://www.invitae.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Swaroop Aradhya

    Swaroop Aradhya, Medical Director

  • Lee Bendekgey

    Lee Bendekgey, Chief Policy Officer

  • Robbie Evans

    Robbie Evans, Chief Strategy Officer

  • Robert Nussbaum

    Robert Nussbaum, Chief Medical Officer

Operating MetricsView all

Samples Accessioned

170K

Q3, 2020

Billable Tests Generated

322K
24.3%

Q1, 2022

Average Revenue per Test

$372
2.9%

Q1, 2022

LocationsView all

1 location detected

  • San Francisco, CA HQ

    United States

    1400 16th St

Invitae Financials

Summary Financials

Revenue (Q3, 2023)
$121.2M
Gross profit (Q3, 2023)
$39.1M
Net income (Q3, 2023)
($942.1M)
Cash (Q3, 2023)
$158.0M
EBIT (Q3, 2023)
($980.2M)

Footer menu